Oncotype DX

Extended Research Has Been Done On A Gene Test That Helps Some Breast-Cancer Patients Determine If They Can Safely Forgo Chemo

A gene test used to guide treatment for early-stage breast cancer proved effective in enabling certain women to safely forgo chemotherapy, in a study that illustrates how genomic information is reshaping cancer care. Researchers said the findings provide validation for the test, called Oncotype DX, which is already in use helping women decide whether chemotherapy …

Extended Research Has Been Done On A Gene Test That Helps Some Breast-Cancer Patients Determine If They Can Safely Forgo Chemo Read More »

Scroll to Top